Colon Cancer Therapy
Research on colon cancer therapy reported by scientists at University of Colorado, Department of Pharmaceutical Sciences
Published in Cancer Weekly, February 2nd, 2010
Fresh data on colon cancer are presented in the report 'Silibinin suppresses growth and induces apoptotic death of human colorectal carcinoma LoVo cells in culture and tumor xenograft.' According to a study from the United States, "Colorectal cancer is one of the leading causes of cancer-related morbidity and mortality. The use of nontoxic phytochemicals in the prevention and intervention of colorectal cancer has been suggested as an alternative to chemotherapy."
"Here we assessed the anticancer efficacy of silibinin against advanced colorectal cancer LoVo cells both in vitro and in vivo. Our results showed that silibinin treatment strongly inhibits the growth of LoVo...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2010-02-02)
More Articles from Cancer Weekly
- American College of Radiology / American Roentgen Ray Society
Digital mammography delivers significantly less radiation than conventional mammography - American College of Radiology / American Roentgen Ray Society
Ultrasound plus proteomic blood analyses may help physicians diagnose early-stage ovarian cancer - BioMed Central
Friendly bacteria love the humble apple - Institut de recherches cliniques de Montreal
A variant of the gene GFI1 predisposes to a subtype of blood cancer - Journal of the National Cancer Institute
3 esophageal cancer cell lines commonly used in research prove to be from other cancers - Journal of the National Cancer Institute
News brief: Informative method to identify biomarkers for guiding therapy decisions - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
